サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1381165

ポリカプロラクトン市場：形状、プロセス、用途別-2023-2030年の世界予測

Polycaprolactone Market by Form (Granules, Pellets), Process (Polycondensation of Carboxylic Acid, Ring Opening Polymerization), Application - Global Forecast 2023-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 182 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
ポリカプロラクトン市場：形状、プロセス、用途別-2023-2030年の世界予測
出版日: 2023年10月16日
発行: 360iResearch
ページ情報: 英文 182 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ポリカプロラクトン市場は、予測期間中のCAGRは6.11%で、2022年の4億8,164万米ドルから2030年には7億7,446万米ドルに達すると予測されます。

ポリカプロラクトンの世界市場

主な市場の統計
市場金額：基準年[2022] 4億8,164万米ドル
推定市場金額[2023] 5億870万米ドル
予測市場金額[2030]USD 774.46 million 7億7,446万米ドル
CAGR（%） 6.11%
ポリカプロラクトン Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスはポリカプロラクトン市場の評価に不可欠なツールです。事業戦略と製品満足度に関連する主要指標を分析し、ベンダーを包括的に評価します。これにより、ユーザーは特定のニーズに合わせた情報に基づいた意思決定を行うことができます。高度な分析により、ベンダーは4つの象限に分類され、それぞれ成功のレベルが異なります：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。この洞察に満ちたフレームワークにより、意思決定者は自信を持って市場をナビゲートすることができます。

市場シェア分析

市場シェア分析では、ベンダーの市場情勢に関する貴重な洞察を提供します。全体収益、顧客ベース、その他の主要指標への影響を評価することで、企業の業績と直面する競合環境を包括的に理解することができます。この分析では、調査期間中の市場シェア獲得、断片化、優位性、業界再編などの競合レベルも明らかにします。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業の市場力学と製品に関する包括的な情報を提供します。

2.市場の開拓度：新興市場と成熟市場セグメントへの浸透度を詳細に分析し、有利なビジネスチャンスを浮き彫りにします。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細情報。

4.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関するインテリジェントな洞察。

本レポートは、以下のような主要な質問に対応しています：

1.ポリカプロラクトン市場の市場規模および予測は？

2.ポリカプロラクトン市場で最も高い投資ポテンシャルを持つ製品、セグメント、用途、分野は？

3.ポリカプロラクトン市場における競争戦略の窓とは？

4.ポリカプロラクトン市場の最新技術動向と規制の枠組みは？

5.ポリカプロラクトン市場における主要ベンダーの市場シェアは？

6.ポリカプロラクトン市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 生分解性素材に対する消費者の意識の向上
      • ヘルスケア分野の急速な成長と医療製品の需要の高まり
    • 抑制要因
      • ポリカプロラクトンおよびポリカプロラクトンベースの製品のコストが高い
    • 機会
      • 新しい製品の革新と発売のための継続的な研究開発
      • 生体適合性および生分解性材料に対する政府の支援的取り組み
    • 課題
      • コスト効率の高い代替品の入手可能性
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 ポリカプロラクトン市場：形態別

  • 顆粒
  • ペレット

第7章 ポリカプロラクトン市場：プロセス別

  • カルボン酸の重縮合
  • 開環重合

第8章 ポリカプロラクトン市場：用途別

  • 生物医学
    • ドラッグデリバリーデバイス
    • 外科用インプラント
  • コーティングとTPU

第9章 南北アメリカのポリカプロラクトン市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域のポリカプロラクトン市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカのポリカプロラクトン市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第13章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Asahi Kasei Chemicals Corporation
    • Ashland Inc.
    • BASF SE
    • Capa by Perstorp Group
    • CELLINK Bioprinting AB
    • Connect Chemicals GmbH
    • Corbion NV
    • Daicel Corporation
    • Durect Corporation
    • Huntsman Corporation
    • LANXESS AG
    • Merck KGaA
    • Nomisma Healthcare Pvt. Ltd.
    • Polylactide Material
    • Polysciences Inc.
    • Shandong INOV Polyurethane Co., Ltd.
  • 主要な製品ポートフォリオ

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. POLYCAPROLACTONE MARKET RESEARCH PROCESS
  • FIGURE 2. POLYCAPROLACTONE MARKET SIZE, 2022 VS 2030
  • FIGURE 3. POLYCAPROLACTONE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. POLYCAPROLACTONE MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 5. POLYCAPROLACTONE MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 6. POLYCAPROLACTONE MARKET DYNAMICS
  • FIGURE 7. POLYCAPROLACTONE MARKET SIZE, BY FORM, 2022 VS 2030 (%)
  • FIGURE 8. POLYCAPROLACTONE MARKET SIZE, BY FORM, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2022 VS 2030 (%)
  • FIGURE 10. POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 12. POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS POLYCAPROLACTONE MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 14. AMERICAS POLYCAPROLACTONE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES POLYCAPROLACTONE MARKET SIZE, BY STATE, 2022 VS 2030 (%)
  • FIGURE 16. UNITED STATES POLYCAPROLACTONE MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC POLYCAPROLACTONE MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC POLYCAPROLACTONE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA POLYCAPROLACTONE MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA POLYCAPROLACTONE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 21. POLYCAPROLACTONE MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 22. POLYCAPROLACTONE MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. POLYCAPROLACTONE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. POLYCAPROLACTONE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL POLYCAPROLACTONE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 6. POLYCAPROLACTONE MARKET SIZE, BY GRANULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. POLYCAPROLACTONE MARKET SIZE, BY PELLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 9. POLYCAPROLACTONE MARKET SIZE, BY POLYCONDENSATION OF CARBOXYLIC ACID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. POLYCAPROLACTONE MARKET SIZE, BY RING OPENING POLYMERIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 14. POLYCAPROLACTONE MARKET SIZE, BY DRUG DELIVERY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. POLYCAPROLACTONE MARKET SIZE, BY SURGICAL IMPLANT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. POLYCAPROLACTONE MARKET SIZE, BY COATING & TPU, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS POLYCAPROLACTONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES POLYCAPROLACTONE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC POLYCAPROLACTONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 53. CHINA POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 56. INDIA POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 57. INDIA POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 58. INDIA POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 60. INDONESIA POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 61. INDONESIA POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 62. INDONESIA POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 64. JAPAN POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 65. JAPAN POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 66. JAPAN POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 68. MALAYSIA POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 69. MALAYSIA POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 70. MALAYSIA POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 72. PHILIPPINES POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 73. PHILIPPINES POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 74. PHILIPPINES POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 76. SINGAPORE POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 77. SINGAPORE POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 78. SINGAPORE POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 80. SOUTH KOREA POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 81. SOUTH KOREA POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 82. SOUTH KOREA POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 84. TAIWAN POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 85. TAIWAN POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 86. TAIWAN POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 88. THAILAND POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 89. THAILAND POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 90. THAILAND POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 92. VIETNAM POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 93. VIETNAM POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 94. VIETNAM POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. VIETNAM POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA POLYCAPROLACTONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 101. DENMARK POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 102. DENMARK POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 103. DENMARK POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. DENMARK POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 105. EGYPT POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 106. EGYPT POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 107. EGYPT POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. EGYPT POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 109. FINLAND POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 110. FINLAND POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 111. FINLAND POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. FINLAND POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 113. FRANCE POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 114. FRANCE POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 115. FRANCE POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. FRANCE POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 117. GERMANY POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 118. GERMANY POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 119. GERMANY POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. GERMANY POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 121. ISRAEL POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 122. ISRAEL POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 123. ISRAEL POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. ISRAEL POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 125. ITALY POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 126. ITALY POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 127. ITALY POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. ITALY POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 129. NETHERLANDS POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 130. NETHERLANDS POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 131. NETHERLANDS POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. NETHERLANDS POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 133. NIGERIA POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 134. NIGERIA POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 135. NIGERIA POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. NIGERIA POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 137. NORWAY POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 138. NORWAY POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 139. NORWAY POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. NORWAY POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 141. POLAND POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 142. POLAND POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 143. POLAND POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. POLAND POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 145. QATAR POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 146. QATAR POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 147. QATAR POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. QATAR POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 149. RUSSIA POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 150. RUSSIA POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 151. RUSSIA POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. RUSSIA POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 153. SAUDI ARABIA POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 154. SAUDI ARABIA POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 155. SAUDI ARABIA POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. SAUDI ARABIA POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 157. SOUTH AFRICA POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 158. SOUTH AFRICA POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 159. SOUTH AFRICA POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH AFRICA POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 161. SPAIN POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 162. SPAIN POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 163. SPAIN POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. SPAIN POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 165. SWEDEN POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 166. SWEDEN POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 167. SWEDEN POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. SWEDEN POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 169. SWITZERLAND POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 170. SWITZERLAND POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 171. SWITZERLAND POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. SWITZERLAND POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 173. TURKEY POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 174. TURKEY POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 175. TURKEY POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. TURKEY POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 177. UNITED ARAB EMIRATES POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 178. UNITED ARAB EMIRATES POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 179. UNITED ARAB EMIRATES POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED KINGDOM POLYCAPROLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED KINGDOM POLYCAPROLACTONE MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED KINGDOM POLYCAPROLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED KINGDOM POLYCAPROLACTONE MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 185. POLYCAPROLACTONE MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 186. POLYCAPROLACTONE MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 187. POLYCAPROLACTONE MARKET LICENSE & PRICING
目次
Product Code: MRR-C002B1C9957D

The Polycaprolactone Market is projected to reach USD 774.46 million by 2030 from USD 481.64 million in 2022, at a CAGR of 6.11% during the forecast period.

Global Polycaprolactone Market

KEY MARKET STATISTICS
Base Year Value [2022] USD 481.64 million
Estimated Year Value [2023] USD 508.70 million
Forecast Year Value [2030] USD 774.46 million
CAGR (%) 6.11%
Polycaprolactone Market - IMG1

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Polycaprolactone Market.

Based on Form, market is studied across Granules and Pellets. The Granules is projected to witness significant market share during forecast period.

Based on Process, market is studied across Polycondensation of Carboxylic Acid and Ring Opening Polymerization. The Polycondensation of Carboxylic Acid is projected to witness significant market share during forecast period.

Based on Application, market is studied across Biomedical and Coating & TPU. The Biomedical is further studied across Drug Delivery Devices and Surgical Implant. The Biomedical is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Asia-Pacific is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Polycaprolactone Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Polycaprolactone Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Polycaprolactone Market, highlighting leading vendors and their innovative profiles. These include Asahi Kasei Chemicals Corporation, Ashland Inc., BASF SE, Capa by Perstorp Group, CELLINK Bioprinting AB, Connect Chemicals GmbH, Corbion NV, Daicel Corporation, Durect Corporation, Huntsman Corporation, LANXESS AG, Merck KGaA, Nomisma Healthcare Pvt. Ltd., Polylactide Material, Polysciences Inc., and Shandong INOV Polyurethane Co., Ltd..

The report offers valuable insights on the following aspects:

1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.

2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.

3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.

4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.

5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast for the Polycaprolactone Market?

2. Which products, segments, applications, and areas hold the highest investment potential in the Polycaprolactone Market?

3. What is the competitive strategic window for identifying opportunities in the Polycaprolactone Market?

4. What are the latest technology trends and regulatory frameworks in the Polycaprolactone Market?

5. What is the market share of the leading vendors in the Polycaprolactone Market?

6. Which modes and strategic moves are suitable for entering the Polycaprolactone Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Polycaprolactone Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing consumer awareness about biodegradable materials
      • 5.1.1.2. Rapid growth of the healthcare sector and rising demand for medical products
    • 5.1.2. Restraints
      • 5.1.2.1. High costs of polycaprolactone and polycaprolactone-based products
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research and development for novel product innovations and launches
      • 5.1.3.2. Supportive government initiatives for biocompatible and biodegradable materials
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of cost-efficient substitute
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Polycaprolactone Market, by Form

  • 6.1. Introduction
  • 6.2. Granules
  • 6.3. Pellets

7. Polycaprolactone Market, by Process

  • 7.1. Introduction
  • 7.2. Polycondensation of Carboxylic Acid
  • 7.3. Ring Opening Polymerization

8. Polycaprolactone Market, by Application

  • 8.1. Introduction
  • 8.2. Biomedical
    • 8.3.1. Drug Delivery Devices
    • 8.3.2. Surgical Implant
  • 8.3. Coating & TPU

9. Americas Polycaprolactone Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Polycaprolactone Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Polycaprolactone Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. Asahi Kasei Chemicals Corporation
    • 13.1.2. Ashland Inc.
    • 13.1.3. BASF SE
    • 13.1.4. Capa by Perstorp Group
    • 13.1.5. CELLINK Bioprinting AB
    • 13.1.6. Connect Chemicals GmbH
    • 13.1.7. Corbion NV
    • 13.1.8. Daicel Corporation
    • 13.1.9. Durect Corporation
    • 13.1.10. Huntsman Corporation
    • 13.1.11. LANXESS AG
    • 13.1.12. Merck KGaA
    • 13.1.13. Nomisma Healthcare Pvt. Ltd.
    • 13.1.14. Polylactide Material
    • 13.1.15. Polysciences Inc.
    • 13.1.16. Shandong INOV Polyurethane Co., Ltd.
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing